NRAS and melanoma: Unlike BRAF mutants, melanoma harboring an NRAS mutation alters GTP hydrolysis to consequently activate the MAPK, PI3K, and RAS-like protein guanine nucleotide exchange factor (GEF) signaling pathways [5].